nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—Conivaptan—Atorvastatin—coronary artery disease	0.31	1	CrCrCtD
Tolvaptan—AVPR1A—coronary artery disease	0.308	1	CbGaD
Tolvaptan—ABCB1—Ticagrelor—coronary artery disease	0.02	0.085	CbGbCtD
Tolvaptan—ABCB1—Clopidogrel—coronary artery disease	0.0124	0.0525	CbGbCtD
Tolvaptan—ABCB1—Perindopril—coronary artery disease	0.0124	0.0525	CbGbCtD
Tolvaptan—CYP3A4—Ticagrelor—coronary artery disease	0.012	0.0509	CbGbCtD
Tolvaptan—ABCB1—Pitavastatin—coronary artery disease	0.0108	0.0459	CbGbCtD
Tolvaptan—ABCB1—Telmisartan—coronary artery disease	0.0108	0.0459	CbGbCtD
Tolvaptan—CYP3A4—Fenofibrate—coronary artery disease	0.0107	0.0454	CbGbCtD
Tolvaptan—ABCB1—Lisinopril—coronary artery disease	0.0102	0.0435	CbGbCtD
Tolvaptan—ABCB1—Enalapril—coronary artery disease	0.0102	0.0435	CbGbCtD
Tolvaptan—ABCB1—Timolol—coronary artery disease	0.00872	0.037	CbGbCtD
Tolvaptan—CYP3A4—Gemfibrozil—coronary artery disease	0.00855	0.0363	CbGbCtD
Tolvaptan—ABCB1—Ezetimibe—coronary artery disease	0.00797	0.0338	CbGbCtD
Tolvaptan—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00777	0.033	CbGbCtD
Tolvaptan—ABCB1—Captopril—coronary artery disease	0.00767	0.0326	CbGbCtD
Tolvaptan—CYP3A4—Clopidogrel—coronary artery disease	0.00741	0.0315	CbGbCtD
Tolvaptan—ABCB1—Simvastatin—coronary artery disease	0.00741	0.0315	CbGbCtD
Tolvaptan—ABCB1—Pravastatin—coronary artery disease	0.00725	0.0308	CbGbCtD
Tolvaptan—ABCB1—Lovastatin—coronary artery disease	0.00725	0.0308	CbGbCtD
Tolvaptan—CYP3A4—Eplerenone—coronary artery disease	0.00689	0.0293	CbGbCtD
Tolvaptan—ABCB1—Atorvastatin—coronary artery disease	0.0066	0.028	CbGbCtD
Tolvaptan—CYP3A4—Enalapril—coronary artery disease	0.00614	0.0261	CbGbCtD
Tolvaptan—ABCB1—Losartan—coronary artery disease	0.00604	0.0257	CbGbCtD
Tolvaptan—CYP3A4—Ezetimibe—coronary artery disease	0.00478	0.0203	CbGbCtD
Tolvaptan—CYP3A4—Rosuvastatin—coronary artery disease	0.00478	0.0203	CbGbCtD
Tolvaptan—CYP3A4—Simvastatin—coronary artery disease	0.00444	0.0189	CbGbCtD
Tolvaptan—CYP3A4—Pravastatin—coronary artery disease	0.00434	0.0185	CbGbCtD
Tolvaptan—CYP3A4—Lovastatin—coronary artery disease	0.00434	0.0185	CbGbCtD
Tolvaptan—CYP3A4—Atorvastatin—coronary artery disease	0.00396	0.0168	CbGbCtD
Tolvaptan—CYP3A4—Losartan—coronary artery disease	0.00362	0.0154	CbGbCtD
Tolvaptan—Conivaptan—AVPR1A—coronary artery disease	0.00163	0.763	CrCbGaD
Tolvaptan—Zafirlukast—CYP2C19—coronary artery disease	0.000218	0.102	CrCbGaD
Tolvaptan—Vismodegib—CYP2C19—coronary artery disease	0.000185	0.0865	CrCbGaD
Tolvaptan—Vismodegib—ALB—coronary artery disease	0.000103	0.048	CrCbGaD
Tolvaptan—Shock—Perindopril—coronary artery disease	6.78e-05	0.000758	CcSEcCtD
Tolvaptan—Anorexia—Captopril—coronary artery disease	6.76e-05	0.000757	CcSEcCtD
Tolvaptan—Nervous system disorder—Perindopril—coronary artery disease	6.76e-05	0.000756	CcSEcCtD
Tolvaptan—Decreased appetite—Niacin—coronary artery disease	6.75e-05	0.000756	CcSEcCtD
Tolvaptan—Hypersensitivity—Clopidogrel—coronary artery disease	6.71e-05	0.000751	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Niacin—coronary artery disease	6.71e-05	0.000751	CcSEcCtD
Tolvaptan—Anaphylactic shock—Furosemide—coronary artery disease	6.7e-05	0.000749	CcSEcCtD
Tolvaptan—Skin disorder—Perindopril—coronary artery disease	6.69e-05	0.000749	CcSEcCtD
Tolvaptan—Body temperature increased—Simvastatin—coronary artery disease	6.69e-05	0.000748	CcSEcCtD
Tolvaptan—Headache—Rosuvastatin—coronary artery disease	6.69e-05	0.000748	CcSEcCtD
Tolvaptan—Hypersensitivity—Lovastatin—coronary artery disease	6.66e-05	0.000746	CcSEcCtD
Tolvaptan—Discomfort—Losartan—coronary artery disease	6.66e-05	0.000745	CcSEcCtD
Tolvaptan—Decreased appetite—Pravastatin—coronary artery disease	6.65e-05	0.000744	CcSEcCtD
Tolvaptan—Dysgeusia—Ramipril—coronary artery disease	6.65e-05	0.000744	CcSEcCtD
Tolvaptan—Asthenia—Fenofibrate—coronary artery disease	6.65e-05	0.000744	CcSEcCtD
Tolvaptan—Malnutrition—Timolol—coronary artery disease	6.64e-05	0.000743	CcSEcCtD
Tolvaptan—Dry mouth—Losartan—coronary artery disease	6.59e-05	0.000738	CcSEcCtD
Tolvaptan—Shock—Furosemide—coronary artery disease	6.59e-05	0.000737	CcSEcCtD
Tolvaptan—Nervous system disorder—Furosemide—coronary artery disease	6.57e-05	0.000735	CcSEcCtD
Tolvaptan—Anorexia—Perindopril—coronary artery disease	6.57e-05	0.000735	CcSEcCtD
Tolvaptan—Pruritus—Fenofibrate—coronary artery disease	6.55e-05	0.000733	CcSEcCtD
Tolvaptan—Feeling abnormal—Olmesartan—coronary artery disease	6.55e-05	0.000733	CcSEcCtD
Tolvaptan—Constipation—Pravastatin—coronary artery disease	6.54e-05	0.000732	CcSEcCtD
Tolvaptan—Hypersensitivity—Ezetimibe—coronary artery disease	6.54e-05	0.000731	CcSEcCtD
Tolvaptan—Asthenia—Clopidogrel—coronary artery disease	6.53e-05	0.000731	CcSEcCtD
Tolvaptan—Skin disorder—Furosemide—coronary artery disease	6.51e-05	0.000728	CcSEcCtD
Tolvaptan—Dysgeusia—Timolol—coronary artery disease	6.5e-05	0.000727	CcSEcCtD
Tolvaptan—Asthenia—Lovastatin—coronary artery disease	6.49e-05	0.000726	CcSEcCtD
Tolvaptan—Anaphylactic shock—Losartan—coronary artery disease	6.46e-05	0.000723	CcSEcCtD
Tolvaptan—Decreased appetite—Trandolapril—coronary artery disease	6.46e-05	0.000723	CcSEcCtD
Tolvaptan—Pruritus—Clopidogrel—coronary artery disease	6.44e-05	0.000721	CcSEcCtD
Tolvaptan—Decreased appetite—Enalapril—coronary artery disease	6.43e-05	0.00072	CcSEcCtD
Tolvaptan—Angiopathy—Lisinopril—coronary artery disease	6.42e-05	0.000718	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Trandolapril—coronary artery disease	6.41e-05	0.000718	CcSEcCtD
Tolvaptan—Pruritus—Lovastatin—coronary artery disease	6.4e-05	0.000716	CcSEcCtD
Tolvaptan—Anorexia—Furosemide—coronary artery disease	6.38e-05	0.000714	CcSEcCtD
Tolvaptan—Mediastinal disorder—Lisinopril—coronary artery disease	6.37e-05	0.000713	CcSEcCtD
Tolvaptan—Asthenia—Ezetimibe—coronary artery disease	6.37e-05	0.000712	CcSEcCtD
Tolvaptan—Shock—Losartan—coronary artery disease	6.36e-05	0.000711	CcSEcCtD
Tolvaptan—Constipation—Trandolapril—coronary artery disease	6.35e-05	0.000711	CcSEcCtD
Tolvaptan—Decreased appetite—Telmisartan—coronary artery disease	6.34e-05	0.00071	CcSEcCtD
Tolvaptan—Nausea—Rosuvastatin—coronary artery disease	6.34e-05	0.000709	CcSEcCtD
Tolvaptan—Diarrhoea—Fenofibrate—coronary artery disease	6.34e-05	0.000709	CcSEcCtD
Tolvaptan—Nervous system disorder—Losartan—coronary artery disease	6.34e-05	0.000709	CcSEcCtD
Tolvaptan—Constipation—Enalapril—coronary artery disease	6.33e-05	0.000708	CcSEcCtD
Tolvaptan—Feeling abnormal—Pravastatin—coronary artery disease	6.3e-05	0.000705	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Telmisartan—coronary artery disease	6.3e-05	0.000705	CcSEcCtD
Tolvaptan—Ill-defined disorder—Ramipril—coronary artery disease	6.3e-05	0.000705	CcSEcCtD
Tolvaptan—Body temperature increased—Olmesartan—coronary artery disease	6.29e-05	0.000703	CcSEcCtD
Tolvaptan—Pruritus—Ezetimibe—coronary artery disease	6.28e-05	0.000702	CcSEcCtD
Tolvaptan—Constipation—Telmisartan—coronary artery disease	6.24e-05	0.000698	CcSEcCtD
Tolvaptan—Hypersensitivity—Simvastatin—coronary artery disease	6.23e-05	0.000698	CcSEcCtD
Tolvaptan—Diarrhoea—Clopidogrel—coronary artery disease	6.23e-05	0.000697	CcSEcCtD
Tolvaptan—Asthenia—Eplerenone—coronary artery disease	6.23e-05	0.000697	CcSEcCtD
Tolvaptan—Diarrhoea—Lovastatin—coronary artery disease	6.19e-05	0.000693	CcSEcCtD
Tolvaptan—Decreased appetite—Captopril—coronary artery disease	6.17e-05	0.00069	CcSEcCtD
Tolvaptan—Anorexia—Losartan—coronary artery disease	6.16e-05	0.000689	CcSEcCtD
Tolvaptan—Nausea—Acetylsalicylic acid—coronary artery disease	6.16e-05	0.000689	CcSEcCtD
Tolvaptan—Malnutrition—Lisinopril—coronary artery disease	6.16e-05	0.000689	CcSEcCtD
Tolvaptan—Pruritus—Eplerenone—coronary artery disease	6.14e-05	0.000687	CcSEcCtD
Tolvaptan—Body temperature increased—Niacin—coronary artery disease	6.14e-05	0.000687	CcSEcCtD
Tolvaptan—Dizziness—Fenofibrate—coronary artery disease	6.13e-05	0.000685	CcSEcCtD
Tolvaptan—Malaise—Ramipril—coronary artery disease	6.12e-05	0.000685	CcSEcCtD
Tolvaptan—Feeling abnormal—Trandolapril—coronary artery disease	6.12e-05	0.000685	CcSEcCtD
Tolvaptan—Feeling abnormal—Enalapril—coronary artery disease	6.1e-05	0.000682	CcSEcCtD
Tolvaptan—Syncope—Ramipril—coronary artery disease	6.09e-05	0.000681	CcSEcCtD
Tolvaptan—Asthenia—Simvastatin—coronary artery disease	6.07e-05	0.000679	CcSEcCtD
Tolvaptan—Diarrhoea—Ezetimibe—coronary artery disease	6.07e-05	0.000679	CcSEcCtD
Tolvaptan—Constipation—Captopril—coronary artery disease	6.07e-05	0.000679	CcSEcCtD
Tolvaptan—Body temperature increased—Pravastatin—coronary artery disease	6.05e-05	0.000677	CcSEcCtD
Tolvaptan—Dysgeusia—Lisinopril—coronary artery disease	6.03e-05	0.000675	CcSEcCtD
Tolvaptan—Dizziness—Clopidogrel—coronary artery disease	6.02e-05	0.000674	CcSEcCtD
Tolvaptan—Feeling abnormal—Telmisartan—coronary artery disease	6.01e-05	0.000673	CcSEcCtD
Tolvaptan—Decreased appetite—Perindopril—coronary artery disease	5.99e-05	0.00067	CcSEcCtD
Tolvaptan—Pruritus—Simvastatin—coronary artery disease	5.99e-05	0.00067	CcSEcCtD
Tolvaptan—Dizziness—Lovastatin—coronary artery disease	5.98e-05	0.000669	CcSEcCtD
Tolvaptan—Loss of consciousness—Ramipril—coronary artery disease	5.97e-05	0.000668	CcSEcCtD
Tolvaptan—Syncope—Timolol—coronary artery disease	5.95e-05	0.000666	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Perindopril—coronary artery disease	5.95e-05	0.000666	CcSEcCtD
Tolvaptan—Diarrhoea—Eplerenone—coronary artery disease	5.94e-05	0.000665	CcSEcCtD
Tolvaptan—Constipation—Perindopril—coronary artery disease	5.89e-05	0.000659	CcSEcCtD
Tolvaptan—Hypersensitivity—Valsartan—coronary artery disease	5.89e-05	0.000659	CcSEcCtD
Tolvaptan—Body temperature increased—Trandolapril—coronary artery disease	5.87e-05	0.000657	CcSEcCtD
Tolvaptan—Dizziness—Ezetimibe—coronary artery disease	5.87e-05	0.000657	CcSEcCtD
Tolvaptan—Body temperature increased—Enalapril—coronary artery disease	5.85e-05	0.000654	CcSEcCtD
Tolvaptan—Feeling abnormal—Captopril—coronary artery disease	5.85e-05	0.000654	CcSEcCtD
Tolvaptan—Loss of consciousness—Timolol—coronary artery disease	5.83e-05	0.000653	CcSEcCtD
Tolvaptan—Decreased appetite—Furosemide—coronary artery disease	5.82e-05	0.000652	CcSEcCtD
Tolvaptan—Headache—Fenofibrate—coronary artery disease	5.8e-05	0.000649	CcSEcCtD
Tolvaptan—Diarrhoea—Simvastatin—coronary artery disease	5.79e-05	0.000648	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Furosemide—coronary artery disease	5.78e-05	0.000647	CcSEcCtD
Tolvaptan—Body temperature increased—Telmisartan—coronary artery disease	5.77e-05	0.000646	CcSEcCtD
Tolvaptan—Dizziness—Eplerenone—coronary artery disease	5.74e-05	0.000643	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	5.74e-05	0.000642	CcSEcCtD
Tolvaptan—Asthenia—Valsartan—coronary artery disease	5.73e-05	0.000642	CcSEcCtD
Tolvaptan—Constipation—Furosemide—coronary artery disease	5.73e-05	0.000641	CcSEcCtD
Tolvaptan—Hypersensitivity—Niacin—coronary artery disease	5.72e-05	0.000641	CcSEcCtD
Tolvaptan—Ill-defined disorder—Lisinopril—coronary artery disease	5.71e-05	0.000639	CcSEcCtD
Tolvaptan—Discomfort—Ramipril—coronary artery disease	5.71e-05	0.000639	CcSEcCtD
Tolvaptan—Asthenia—Olmesartan—coronary artery disease	5.71e-05	0.000638	CcSEcCtD
Tolvaptan—Headache—Clopidogrel—coronary artery disease	5.7e-05	0.000638	CcSEcCtD
Tolvaptan—Feeling abnormal—Perindopril—coronary artery disease	5.68e-05	0.000635	CcSEcCtD
Tolvaptan—Headache—Lovastatin—coronary artery disease	5.67e-05	0.000634	CcSEcCtD
Tolvaptan—Pruritus—Valsartan—coronary artery disease	5.65e-05	0.000633	CcSEcCtD
Tolvaptan—Dry mouth—Ramipril—coronary artery disease	5.65e-05	0.000633	CcSEcCtD
Tolvaptan—Hypersensitivity—Pravastatin—coronary artery disease	5.64e-05	0.000631	CcSEcCtD
Tolvaptan—Pruritus—Olmesartan—coronary artery disease	5.63e-05	0.00063	CcSEcCtD
Tolvaptan—Decreased appetite—Losartan—coronary artery disease	5.62e-05	0.000629	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	5.61e-05	0.000628	CcSEcCtD
Tolvaptan—Body temperature increased—Captopril—coronary artery disease	5.61e-05	0.000628	CcSEcCtD
Tolvaptan—Dizziness—Simvastatin—coronary artery disease	5.59e-05	0.000626	CcSEcCtD
Tolvaptan—Discomfort—Timolol—coronary artery disease	5.58e-05	0.000625	CcSEcCtD
Tolvaptan—Asthenia—Niacin—coronary artery disease	5.57e-05	0.000624	CcSEcCtD
Tolvaptan—Headache—Ezetimibe—coronary artery disease	5.56e-05	0.000622	CcSEcCtD
Tolvaptan—Malaise—Lisinopril—coronary artery disease	5.55e-05	0.000621	CcSEcCtD
Tolvaptan—Anaphylactic shock—Ramipril—coronary artery disease	5.54e-05	0.00062	CcSEcCtD
Tolvaptan—Dry mouth—Timolol—coronary artery disease	5.53e-05	0.000618	CcSEcCtD
Tolvaptan—Constipation—Losartan—coronary artery disease	5.53e-05	0.000618	CcSEcCtD
Tolvaptan—Syncope—Lisinopril—coronary artery disease	5.52e-05	0.000618	CcSEcCtD
Tolvaptan—Feeling abnormal—Furosemide—coronary artery disease	5.52e-05	0.000618	CcSEcCtD
Tolvaptan—Nausea—Fenofibrate—coronary artery disease	5.5e-05	0.000616	CcSEcCtD
Tolvaptan—Pruritus—Niacin—coronary artery disease	5.5e-05	0.000615	CcSEcCtD
Tolvaptan—Asthenia—Pravastatin—coronary artery disease	5.49e-05	0.000614	CcSEcCtD
Tolvaptan—Hypersensitivity—Trandolapril—coronary artery disease	5.47e-05	0.000612	CcSEcCtD
Tolvaptan—Diarrhoea—Valsartan—coronary artery disease	5.47e-05	0.000612	CcSEcCtD
Tolvaptan—Shock—Ramipril—coronary artery disease	5.45e-05	0.00061	CcSEcCtD
Tolvaptan—Hypersensitivity—Enalapril—coronary artery disease	5.45e-05	0.00061	CcSEcCtD
Tolvaptan—Body temperature increased—Perindopril—coronary artery disease	5.45e-05	0.000609	CcSEcCtD
Tolvaptan—Diarrhoea—Olmesartan—coronary artery disease	5.44e-05	0.000609	CcSEcCtD
Tolvaptan—Headache—Eplerenone—coronary artery disease	5.44e-05	0.000609	CcSEcCtD
Tolvaptan—Nervous system disorder—Ramipril—coronary artery disease	5.43e-05	0.000608	CcSEcCtD
Tolvaptan—Anaphylactic shock—Timolol—coronary artery disease	5.42e-05	0.000606	CcSEcCtD
Tolvaptan—Pruritus—Pravastatin—coronary artery disease	5.41e-05	0.000606	CcSEcCtD
Tolvaptan—Loss of consciousness—Lisinopril—coronary artery disease	5.41e-05	0.000606	CcSEcCtD
Tolvaptan—Nausea—Clopidogrel—coronary artery disease	5.41e-05	0.000605	CcSEcCtD
Tolvaptan—Skin disorder—Ramipril—coronary artery disease	5.38e-05	0.000602	CcSEcCtD
Tolvaptan—Hypersensitivity—Telmisartan—coronary artery disease	5.38e-05	0.000602	CcSEcCtD
Tolvaptan—Nausea—Lovastatin—coronary artery disease	5.37e-05	0.000601	CcSEcCtD
Tolvaptan—Asthenia—Trandolapril—coronary artery disease	5.33e-05	0.000596	CcSEcCtD
Tolvaptan—Shock—Timolol—coronary artery disease	5.33e-05	0.000596	CcSEcCtD
Tolvaptan—Feeling abnormal—Losartan—coronary artery disease	5.33e-05	0.000596	CcSEcCtD
Tolvaptan—Diarrhoea—Niacin—coronary artery disease	5.32e-05	0.000595	CcSEcCtD
Tolvaptan—Nervous system disorder—Timolol—coronary artery disease	5.31e-05	0.000594	CcSEcCtD
Tolvaptan—Asthenia—Enalapril—coronary artery disease	5.31e-05	0.000594	CcSEcCtD
Tolvaptan—Headache—Simvastatin—coronary artery disease	5.3e-05	0.000593	CcSEcCtD
Tolvaptan—Body temperature increased—Furosemide—coronary artery disease	5.29e-05	0.000592	CcSEcCtD
Tolvaptan—Dizziness—Valsartan—coronary artery disease	5.28e-05	0.000591	CcSEcCtD
Tolvaptan—Anorexia—Ramipril—coronary artery disease	5.28e-05	0.000591	CcSEcCtD
Tolvaptan—Nausea—Ezetimibe—coronary artery disease	5.27e-05	0.00059	CcSEcCtD
Tolvaptan—Skin disorder—Timolol—coronary artery disease	5.26e-05	0.000589	CcSEcCtD
Tolvaptan—Dizziness—Olmesartan—coronary artery disease	5.26e-05	0.000588	CcSEcCtD
Tolvaptan—Pruritus—Trandolapril—coronary artery disease	5.26e-05	0.000588	CcSEcCtD
Tolvaptan—Asthenia—Telmisartan—coronary artery disease	5.24e-05	0.000586	CcSEcCtD
Tolvaptan—Pruritus—Enalapril—coronary artery disease	5.23e-05	0.000586	CcSEcCtD
Tolvaptan—Diarrhoea—Pravastatin—coronary artery disease	5.23e-05	0.000586	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	5.21e-05	0.000583	CcSEcCtD
Tolvaptan—Discomfort—Lisinopril—coronary artery disease	5.18e-05	0.00058	CcSEcCtD
Tolvaptan—Anorexia—Timolol—coronary artery disease	5.16e-05	0.000578	CcSEcCtD
Tolvaptan—Pruritus—Telmisartan—coronary artery disease	5.16e-05	0.000578	CcSEcCtD
Tolvaptan—Nausea—Eplerenone—coronary artery disease	5.16e-05	0.000577	CcSEcCtD
Tolvaptan—Dizziness—Niacin—coronary artery disease	5.14e-05	0.000575	CcSEcCtD
Tolvaptan—Dry mouth—Lisinopril—coronary artery disease	5.13e-05	0.000574	CcSEcCtD
Tolvaptan—Body temperature increased—Losartan—coronary artery disease	5.11e-05	0.000572	CcSEcCtD
Tolvaptan—Asthenia—Captopril—coronary artery disease	5.09e-05	0.00057	CcSEcCtD
Tolvaptan—Diarrhoea—Trandolapril—coronary artery disease	5.08e-05	0.000569	CcSEcCtD
Tolvaptan—Diarrhoea—Enalapril—coronary artery disease	5.06e-05	0.000566	CcSEcCtD
Tolvaptan—Dizziness—Pravastatin—coronary artery disease	5.06e-05	0.000566	CcSEcCtD
Tolvaptan—Nausea—Simvastatin—coronary artery disease	5.03e-05	0.000562	CcSEcCtD
Tolvaptan—Anaphylactic shock—Lisinopril—coronary artery disease	5.03e-05	0.000562	CcSEcCtD
Tolvaptan—Pruritus—Captopril—coronary artery disease	5.02e-05	0.000562	CcSEcCtD
Tolvaptan—Headache—Valsartan—coronary artery disease	5.01e-05	0.00056	CcSEcCtD
Tolvaptan—Diarrhoea—Telmisartan—coronary artery disease	4.99e-05	0.000559	CcSEcCtD
Tolvaptan—Headache—Olmesartan—coronary artery disease	4.98e-05	0.000557	CcSEcCtD
Tolvaptan—Shock—Lisinopril—coronary artery disease	4.94e-05	0.000553	CcSEcCtD
Tolvaptan—Asthenia—Perindopril—coronary artery disease	4.94e-05	0.000553	CcSEcCtD
Tolvaptan—Hypersensitivity—Furosemide—coronary artery disease	4.93e-05	0.000552	CcSEcCtD
Tolvaptan—Dizziness—Trandolapril—coronary artery disease	4.91e-05	0.00055	CcSEcCtD
Tolvaptan—Dizziness—Enalapril—coronary artery disease	4.89e-05	0.000547	CcSEcCtD
Tolvaptan—Skin disorder—Lisinopril—coronary artery disease	4.88e-05	0.000546	CcSEcCtD
Tolvaptan—Pruritus—Perindopril—coronary artery disease	4.87e-05	0.000545	CcSEcCtD
Tolvaptan—Headache—Niacin—coronary artery disease	4.87e-05	0.000545	CcSEcCtD
Tolvaptan—Diarrhoea—Captopril—coronary artery disease	4.85e-05	0.000543	CcSEcCtD
Tolvaptan—Dizziness—Telmisartan—coronary artery disease	4.83e-05	0.00054	CcSEcCtD
Tolvaptan—Decreased appetite—Ramipril—coronary artery disease	4.82e-05	0.000539	CcSEcCtD
Tolvaptan—Asthenia—Furosemide—coronary artery disease	4.81e-05	0.000538	CcSEcCtD
Tolvaptan—Headache—Pravastatin—coronary artery disease	4.79e-05	0.000536	CcSEcCtD
Tolvaptan—Anorexia—Lisinopril—coronary artery disease	4.79e-05	0.000536	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Ramipril—coronary artery disease	4.78e-05	0.000535	CcSEcCtD
Tolvaptan—Hypersensitivity—Losartan—coronary artery disease	4.76e-05	0.000533	CcSEcCtD
Tolvaptan—Nausea—Valsartan—coronary artery disease	4.75e-05	0.000531	CcSEcCtD
Tolvaptan—Pruritus—Furosemide—coronary artery disease	4.74e-05	0.00053	CcSEcCtD
Tolvaptan—Constipation—Ramipril—coronary artery disease	4.74e-05	0.00053	CcSEcCtD
Tolvaptan—Nausea—Olmesartan—coronary artery disease	4.72e-05	0.000529	CcSEcCtD
Tolvaptan—Diarrhoea—Perindopril—coronary artery disease	4.71e-05	0.000527	CcSEcCtD
Tolvaptan—Decreased appetite—Timolol—coronary artery disease	4.71e-05	0.000527	CcSEcCtD
Tolvaptan—Dizziness—Captopril—coronary artery disease	4.69e-05	0.000525	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Timolol—coronary artery disease	4.68e-05	0.000523	CcSEcCtD
Tolvaptan—Headache—Trandolapril—coronary artery disease	4.65e-05	0.000521	CcSEcCtD
Tolvaptan—Asthenia—Losartan—coronary artery disease	4.64e-05	0.000519	CcSEcCtD
Tolvaptan—Headache—Enalapril—coronary artery disease	4.63e-05	0.000519	CcSEcCtD
Tolvaptan—Nausea—Niacin—coronary artery disease	4.61e-05	0.000516	CcSEcCtD
Tolvaptan—Diarrhoea—Furosemide—coronary artery disease	4.58e-05	0.000513	CcSEcCtD
Tolvaptan—Pruritus—Losartan—coronary artery disease	4.57e-05	0.000512	CcSEcCtD
Tolvaptan—Headache—Telmisartan—coronary artery disease	4.57e-05	0.000512	CcSEcCtD
Tolvaptan—Feeling abnormal—Ramipril—coronary artery disease	4.57e-05	0.000511	CcSEcCtD
Tolvaptan—Dizziness—Perindopril—coronary artery disease	4.56e-05	0.00051	CcSEcCtD
Tolvaptan—Nausea—Pravastatin—coronary artery disease	4.54e-05	0.000508	CcSEcCtD
Tolvaptan—Feeling abnormal—Timolol—coronary artery disease	4.46e-05	0.0005	CcSEcCtD
Tolvaptan—Headache—Captopril—coronary artery disease	4.45e-05	0.000497	CcSEcCtD
Tolvaptan—Dizziness—Furosemide—coronary artery disease	4.43e-05	0.000496	CcSEcCtD
Tolvaptan—Diarrhoea—Losartan—coronary artery disease	4.42e-05	0.000495	CcSEcCtD
Tolvaptan—Nausea—Trandolapril—coronary artery disease	4.41e-05	0.000494	CcSEcCtD
Tolvaptan—Nausea—Enalapril—coronary artery disease	4.39e-05	0.000492	CcSEcCtD
Tolvaptan—Body temperature increased—Ramipril—coronary artery disease	4.38e-05	0.00049	CcSEcCtD
Tolvaptan—Decreased appetite—Lisinopril—coronary artery disease	4.37e-05	0.000489	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Lisinopril—coronary artery disease	4.34e-05	0.000485	CcSEcCtD
Tolvaptan—Nausea—Telmisartan—coronary artery disease	4.33e-05	0.000485	CcSEcCtD
Tolvaptan—Headache—Perindopril—coronary artery disease	4.32e-05	0.000483	CcSEcCtD
Tolvaptan—Constipation—Lisinopril—coronary artery disease	4.3e-05	0.000481	CcSEcCtD
Tolvaptan—Body temperature increased—Timolol—coronary artery disease	4.28e-05	0.000479	CcSEcCtD
Tolvaptan—Dizziness—Losartan—coronary artery disease	4.27e-05	0.000478	CcSEcCtD
Tolvaptan—Nausea—Captopril—coronary artery disease	4.21e-05	0.000472	CcSEcCtD
Tolvaptan—Headache—Furosemide—coronary artery disease	4.2e-05	0.00047	CcSEcCtD
Tolvaptan—Feeling abnormal—Lisinopril—coronary artery disease	4.14e-05	0.000463	CcSEcCtD
Tolvaptan—Nausea—Perindopril—coronary artery disease	4.09e-05	0.000458	CcSEcCtD
Tolvaptan—Hypersensitivity—Ramipril—coronary artery disease	4.08e-05	0.000457	CcSEcCtD
Tolvaptan—Headache—Losartan—coronary artery disease	4.05e-05	0.000453	CcSEcCtD
Tolvaptan—Hypersensitivity—Timolol—coronary artery disease	3.99e-05	0.000447	CcSEcCtD
Tolvaptan—Nausea—Furosemide—coronary artery disease	3.98e-05	0.000445	CcSEcCtD
Tolvaptan—Asthenia—Ramipril—coronary artery disease	3.98e-05	0.000445	CcSEcCtD
Tolvaptan—Body temperature increased—Lisinopril—coronary artery disease	3.97e-05	0.000445	CcSEcCtD
Tolvaptan—Pruritus—Ramipril—coronary artery disease	3.92e-05	0.000439	CcSEcCtD
Tolvaptan—Asthenia—Timolol—coronary artery disease	3.89e-05	0.000435	CcSEcCtD
Tolvaptan—Nausea—Losartan—coronary artery disease	3.84e-05	0.00043	CcSEcCtD
Tolvaptan—Pruritus—Timolol—coronary artery disease	3.83e-05	0.000429	CcSEcCtD
Tolvaptan—Diarrhoea—Ramipril—coronary artery disease	3.79e-05	0.000424	CcSEcCtD
Tolvaptan—Diarrhoea—Timolol—coronary artery disease	3.71e-05	0.000415	CcSEcCtD
Tolvaptan—Hypersensitivity—Lisinopril—coronary artery disease	3.7e-05	0.000414	CcSEcCtD
Tolvaptan—Dizziness—Ramipril—coronary artery disease	3.66e-05	0.00041	CcSEcCtD
Tolvaptan—Asthenia—Lisinopril—coronary artery disease	3.61e-05	0.000403	CcSEcCtD
Tolvaptan—Dizziness—Timolol—coronary artery disease	3.58e-05	0.000401	CcSEcCtD
Tolvaptan—Pruritus—Lisinopril—coronary artery disease	3.56e-05	0.000398	CcSEcCtD
Tolvaptan—Headache—Ramipril—coronary artery disease	3.47e-05	0.000388	CcSEcCtD
Tolvaptan—Diarrhoea—Lisinopril—coronary artery disease	3.44e-05	0.000385	CcSEcCtD
Tolvaptan—Headache—Timolol—coronary artery disease	3.39e-05	0.00038	CcSEcCtD
Tolvaptan—Dizziness—Lisinopril—coronary artery disease	3.32e-05	0.000372	CcSEcCtD
Tolvaptan—Nausea—Ramipril—coronary artery disease	3.29e-05	0.000368	CcSEcCtD
Tolvaptan—Nausea—Timolol—coronary artery disease	3.22e-05	0.00036	CcSEcCtD
Tolvaptan—Headache—Lisinopril—coronary artery disease	3.15e-05	0.000352	CcSEcCtD
Tolvaptan—Nausea—Lisinopril—coronary artery disease	2.98e-05	0.000334	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—GSK3B—coronary artery disease	6.95e-06	0.000126	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PYGB—coronary artery disease	6.93e-06	0.000126	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CKB—coronary artery disease	6.93e-06	0.000126	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—TFRC—coronary artery disease	6.93e-06	0.000126	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GSK3B—coronary artery disease	6.9e-06	0.000125	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—POMC—coronary artery disease	6.89e-06	0.000125	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CREB1—coronary artery disease	6.89e-06	0.000125	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—POMC—coronary artery disease	6.84e-06	0.000124	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CREB1—coronary artery disease	6.84e-06	0.000124	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCL2—coronary artery disease	6.74e-06	0.000122	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6R—coronary artery disease	6.72e-06	0.000122	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL2—coronary artery disease	6.7e-06	0.000121	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—coronary artery disease	6.69e-06	0.000121	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6R—coronary artery disease	6.67e-06	0.000121	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IGF1—coronary artery disease	6.63e-06	0.00012	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—MAPK1—coronary artery disease	6.6e-06	0.00012	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IGF1—coronary artery disease	6.58e-06	0.000119	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—MAPK1—coronary artery disease	6.55e-06	0.000119	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PLIN1—coronary artery disease	6.52e-06	0.000118	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTM2—coronary artery disease	6.52e-06	0.000118	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—COX5B—coronary artery disease	6.52e-06	0.000118	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—DLAT—coronary artery disease	6.52e-06	0.000118	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PFKFB3—coronary artery disease	6.52e-06	0.000118	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—PLAT—coronary artery disease	6.44e-06	0.000117	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PIK3CA—coronary artery disease	6.3e-06	0.000114	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SERPINE1—coronary artery disease	6.3e-06	0.000114	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PIK3CA—coronary artery disease	6.26e-06	0.000113	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SERPINE1—coronary artery disease	6.25e-06	0.000113	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—coronary artery disease	6.21e-06	0.000113	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SULT1E1—coronary artery disease	6.18e-06	0.000112	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FGF2—coronary artery disease	6.09e-06	0.00011	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	6.06e-06	0.00011	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CKM—coronary artery disease	6.06e-06	0.00011	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPAP2B—coronary artery disease	6.06e-06	0.00011	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FGF2—coronary artery disease	6.05e-06	0.00011	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—coronary artery disease	6.04e-06	0.00011	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOS3—coronary artery disease	6.01e-06	0.000109	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOS3—coronary artery disease	5.97e-06	0.000108	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AKR1B1—coronary artery disease	5.89e-06	0.000107	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HK2—coronary artery disease	5.89e-06	0.000107	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—JAK2—coronary artery disease	5.84e-06	0.000106	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—JAK2—coronary artery disease	5.8e-06	0.000105	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PIK3CA—coronary artery disease	5.73e-06	0.000104	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PIK3CA—coronary artery disease	5.68e-06	0.000103	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC27A1—coronary artery disease	5.65e-06	0.000102	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SULT4A1—coronary artery disease	5.63e-06	0.000102	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PDK4—coronary artery disease	5.63e-06	0.000102	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	5.63e-06	0.000102	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PYGM—coronary artery disease	5.63e-06	0.000102	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CKMT2—coronary artery disease	5.63e-06	0.000102	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—POMC—coronary artery disease	5.62e-06	0.000102	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CPT1B—coronary artery disease	5.54e-06	0.0001	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LCAT—coronary artery disease	5.54e-06	0.0001	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—PLG—coronary artery disease	5.48e-06	9.93e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOA4—coronary artery disease	5.44e-06	9.86e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCL8—coronary artery disease	5.33e-06	9.67e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCL8—coronary artery disease	5.29e-06	9.6e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—coronary artery disease	5.27e-06	9.55e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GCLM—coronary artery disease	5.25e-06	9.52e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PDHA1—coronary artery disease	5.25e-06	9.52e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—AKT1—coronary artery disease	5.15e-06	9.34e-05	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—AKT1—coronary artery disease	5.11e-06	9.27e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CASP3—coronary artery disease	5.1e-06	9.25e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—TXNRD1—coronary artery disease	5.09e-06	9.22e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP11B2—coronary artery disease	5.09e-06	9.22e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6—coronary artery disease	5.07e-06	9.19e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CASP3—coronary artery disease	5.07e-06	9.18e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—HMOX1—coronary artery disease	5.05e-06	9.16e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6—coronary artery disease	5.03e-06	9.13e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GYG1—coronary artery disease	5.02e-06	9.1e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GATM—coronary artery disease	5.02e-06	9.1e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HMGCS2—coronary artery disease	5.02e-06	9.1e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LDHA—coronary artery disease	5.02e-06	9.1e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PFKM—coronary artery disease	5.02e-06	9.1e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GK—coronary artery disease	5.02e-06	9.1e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC22A3—coronary artery disease	5.01e-06	9.08e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCND1—coronary artery disease	4.97e-06	9e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ARNTL—coronary artery disease	4.94e-06	8.95e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HADH—coronary artery disease	4.94e-06	8.95e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCND1—coronary artery disease	4.93e-06	8.94e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—APOB—coronary artery disease	4.84e-06	8.78e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—coronary artery disease	4.83e-06	8.76e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MMP9—coronary artery disease	4.82e-06	8.74e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AK1—coronary artery disease	4.79e-06	8.68e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GCH1—coronary artery disease	4.79e-06	8.68e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MMP9—coronary artery disease	4.79e-06	8.68e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—coronary artery disease	4.74e-06	8.59e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GPX2—coronary artery disease	4.68e-06	8.49e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOA2—coronary artery disease	4.68e-06	8.49e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PLA2G2A—coronary artery disease	4.68e-06	8.49e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—AKT1—coronary artery disease	4.68e-06	8.48e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—AKT1—coronary artery disease	4.64e-06	8.42e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HK1—coronary artery disease	4.62e-06	8.38e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCG5—coronary artery disease	4.62e-06	8.38e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GPX4—coronary artery disease	4.62e-06	8.38e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SULT1A1—coronary artery disease	4.62e-06	8.38e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MDH2—coronary artery disease	4.59e-06	8.33e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPAT—coronary artery disease	4.59e-06	8.33e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLCD1—coronary artery disease	4.59e-06	8.33e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—UGCG—coronary artery disease	4.59e-06	8.33e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HADHA—coronary artery disease	4.57e-06	8.28e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTA1—coronary artery disease	4.52e-06	8.19e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	4.51e-06	8.18e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LPA—coronary artery disease	4.47e-06	8.1e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PGM1—coronary artery disease	4.42e-06	8.01e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—VEGFA—coronary artery disease	4.33e-06	7.85e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PLCB3—coronary artery disease	4.32e-06	7.84e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VEGFA—coronary artery disease	4.3e-06	7.79e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOA5—coronary artery disease	4.28e-06	7.76e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CKB—coronary artery disease	4.27e-06	7.74e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PYGB—coronary artery disease	4.27e-06	7.74e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—P4HB—coronary artery disease	4.2e-06	7.61e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PLA2G1B—coronary artery disease	4.12e-06	7.47e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	4.11e-06	7.46e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—COX5B—coronary artery disease	4.01e-06	7.28e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLIN1—coronary artery disease	4.01e-06	7.28e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTM2—coronary artery disease	4.01e-06	7.28e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—DLAT—coronary artery disease	4.01e-06	7.28e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PFKFB3—coronary artery disease	4.01e-06	7.28e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TGFB1—coronary artery disease	3.97e-06	7.21e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TGFB1—coronary artery disease	3.95e-06	7.15e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAPK1—coronary artery disease	3.9e-06	7.07e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—VCAN—coronary artery disease	3.88e-06	7.04e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAPK1—coronary artery disease	3.87e-06	7.02e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALDOA—coronary artery disease	3.85e-06	6.99e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—APOA1—coronary artery disease	3.83e-06	6.94e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SULT1E1—coronary artery disease	3.81e-06	6.9e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—DCN—coronary artery disease	3.74e-06	6.78e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALDH2—coronary artery disease	3.64e-06	6.6e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AKR1B1—coronary artery disease	3.63e-06	6.58e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HK2—coronary artery disease	3.63e-06	6.58e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3C2A—coronary artery disease	3.55e-06	6.43e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LIPC—coronary artery disease	3.55e-06	6.43e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HBA1—coronary artery disease	3.55e-06	6.43e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP2C19—coronary artery disease	3.55e-06	6.43e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOC3—coronary artery disease	3.53e-06	6.39e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LDLR—coronary artery disease	3.5e-06	6.35e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC27A1—coronary artery disease	3.48e-06	6.31e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC9A1—coronary artery disease	3.46e-06	6.28e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTT1—coronary artery disease	3.46e-06	6.28e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GCLC—coronary artery disease	3.42e-06	6.2e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CETP—coronary artery disease	3.42e-06	6.2e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LCAT—coronary artery disease	3.41e-06	6.19e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CPT1B—coronary artery disease	3.41e-06	6.19e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SDC1—coronary artery disease	3.38e-06	6.14e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CA—coronary artery disease	3.38e-06	6.13e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	3.36e-06	6.09e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CA—coronary artery disease	3.36e-06	6.09e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOA4—coronary artery disease	3.35e-06	6.07e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PDHA1—coronary artery disease	3.24e-06	5.87e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GCLM—coronary artery disease	3.24e-06	5.87e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PSMB5—coronary artery disease	3.2e-06	5.8e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PSMA6—coronary artery disease	3.2e-06	5.8e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—TXNRD1—coronary artery disease	3.13e-06	5.68e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP11B2—coronary artery disease	3.13e-06	5.68e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CTGF—coronary artery disease	3.12e-06	5.66e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HMGCR—coronary artery disease	3.1e-06	5.61e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GOT2—coronary artery disease	3.1e-06	5.61e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC22A3—coronary artery disease	3.09e-06	5.6e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ARNTL—coronary artery disease	3.04e-06	5.52e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HADH—coronary artery disease	3.04e-06	5.52e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	3.03e-06	5.5e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6—coronary artery disease	2.99e-06	5.43e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6—coronary artery disease	2.97e-06	5.39e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOA2—coronary artery disease	2.88e-06	5.23e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	2.88e-06	5.23e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GPX2—coronary artery disease	2.88e-06	5.23e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SULT1A1—coronary artery disease	2.85e-06	5.16e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HK1—coronary artery disease	2.85e-06	5.16e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCG5—coronary artery disease	2.85e-06	5.16e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GPX4—coronary artery disease	2.85e-06	5.16e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PLCB1—coronary artery disease	2.85e-06	5.16e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HADHA—coronary artery disease	2.81e-06	5.1e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTA1—coronary artery disease	2.78e-06	5.04e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AKT1—coronary artery disease	2.76e-06	5.01e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCA1—coronary artery disease	2.76e-06	5e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LPA—coronary artery disease	2.75e-06	4.99e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AKT1—coronary artery disease	2.74e-06	4.97e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GGT1—coronary artery disease	2.67e-06	4.84e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GOT1—coronary artery disease	2.67e-06	4.84e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLCB3—coronary artery disease	2.66e-06	4.83e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOA5—coronary artery disease	2.64e-06	4.78e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—P4HB—coronary artery disease	2.59e-06	4.69e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	2.54e-06	4.6e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTP1—coronary artery disease	2.4e-06	4.35e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—VCAN—coronary artery disease	2.39e-06	4.34e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARGC1A—coronary artery disease	2.38e-06	4.31e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.37e-06	4.31e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HMOX1—coronary artery disease	2.37e-06	4.29e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CAT—coronary artery disease	2.34e-06	4.23e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—DCN—coronary artery disease	2.31e-06	4.18e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOB—coronary artery disease	2.27e-06	4.11e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.24e-06	4.07e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTM1—coronary artery disease	2.21e-06	4e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LIPC—coronary artery disease	2.19e-06	3.96e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HBA1—coronary artery disease	2.19e-06	3.96e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.19e-06	3.96e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.19e-06	3.96e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOC3—coronary artery disease	2.17e-06	3.94e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LPL—coronary artery disease	2.16e-06	3.92e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LDLR—coronary artery disease	2.16e-06	3.91e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.13e-06	3.87e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.13e-06	3.87e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GPX1—coronary artery disease	2.11e-06	3.83e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GCLC—coronary artery disease	2.11e-06	3.82e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CETP—coronary artery disease	2.11e-06	3.82e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SDC1—coronary artery disease	2.08e-06	3.78e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CD36—coronary artery disease	2.06e-06	3.73e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPP2CA—coronary artery disease	2.03e-06	3.68e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.97e-06	3.57e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.97e-06	3.57e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MTHFR—coronary artery disease	1.95e-06	3.53e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CTGF—coronary artery disease	1.92e-06	3.49e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GOT2—coronary artery disease	1.91e-06	3.46e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.91e-06	3.46e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AGT—coronary artery disease	1.85e-06	3.36e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOE—coronary artery disease	1.81e-06	3.29e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOA1—coronary artery disease	1.79e-06	3.25e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.75e-06	3.18e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.7e-06	3.08e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GOT1—coronary artery disease	1.65e-06	2.98e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GGT1—coronary artery disease	1.65e-06	2.98e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARG—coronary artery disease	1.58e-06	2.87e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—POMC—coronary artery disease	1.56e-06	2.83e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.48e-06	2.68e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.46e-06	2.66e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.46e-06	2.64e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CAT—coronary artery disease	1.44e-06	2.61e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALB—coronary artery disease	1.42e-06	2.58e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOB—coronary artery disease	1.4e-06	2.53e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NOS3—coronary artery disease	1.36e-06	2.46e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.36e-06	2.46e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LPL—coronary artery disease	1.33e-06	2.42e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GPX1—coronary artery disease	1.3e-06	2.36e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CD36—coronary artery disease	1.27e-06	2.3e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.25e-06	2.27e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS2—coronary artery disease	1.24e-06	2.25e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.2e-06	2.18e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AGT—coronary artery disease	1.14e-06	2.07e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOE—coronary artery disease	1.12e-06	2.03e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOA1—coronary artery disease	1.11e-06	2e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARG—coronary artery disease	9.74e-07	1.77e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—POMC—coronary artery disease	9.6e-07	1.74e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALB—coronary artery disease	8.76e-07	1.59e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NOS3—coronary artery disease	8.38e-07	1.52e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS2—coronary artery disease	7.66e-07	1.39e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CA—coronary artery disease	7.65e-07	1.39e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AKT1—coronary artery disease	6.25e-07	1.13e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CA—coronary artery disease	4.71e-07	8.54e-06	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AKT1—coronary artery disease	3.85e-07	6.98e-06	CbGpPWpGaD
